Invesco
SRTA

Invesco’s Strata Critical Medical Inc SRTA Stock Holding History

Invesco’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$113K Sell
27,134
-4,941
-15% -$23.8K ﹤0.01% 3608
2025
Q4 		$154K Sell
32,075
-21,344
-40% -$103K ﹤0.01% 3584
2025
Q3 		$270K Sell
53,419
-20,058
-27% -$88.6K ﹤0.01% 3454
2025
Q2 		$296K Sell
73,477
-18,037
-20% -$58.7K ﹤0.01% 3365
2025
Q1 		$250K Sell
91,514
-20,648
-18% -$74.1K ﹤0.01% 3420
2024
Q4 		$477K Buy
112,162
+1,580
+1% +$6.01K ﹤0.01% 3254
2024
Q3 		$325K Sell
110,582
-565
-0.5% -$1.8K ﹤0.01% 3392
2024
Q2 		$387K Sell
111,147
-1,764
-2% -$5.88K ﹤0.01% 3387
2024
Q1 		$322K Buy
112,911
+89,778
+388% +$277K ﹤0.01% 3502
2023
Q4 		$81.7K Buy
23,133
+5,303
+30% +$15.2K ﹤0.01% 3707
2023
Q3 		$46.2K Hold
17,830
– – ﹤0.01% 3802
2023
Q2 		$70.3K Sell
17,830
-2
-0% -$6 ﹤0.01% 3783
2023
Q1 		$60.3K Sell
17,832
-1,241
-7% -$5.06K ﹤0.01% 3749
2022
Q4 		$68.3K Sell
19,073
-2,283
-11% -$9.76K ﹤0.01% 3882
2022
Q3 		$86K Sell
21,356
-48
-0.2% -$247 ﹤0.01% 3860
2022
Q2 		$96K Buy
+21,404
New +$154K ﹤0.01% 3893

Other funds holding SRTA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $221M AUM
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco's SRTA Position: Q1 2026 in Review

Invesco reduced its Strata Critical Medical Inc (SRTA) stake by 15% in Q1 2026, selling an estimated $23.8K and leaving 27,134 shares worth $113K. The position accounts for ﹤0.01% of the portfolio, ranked #3608.

Invesco first reported a position in SRTA in Q2 2022 and has held it in 16 quarters since. The position peaked at $477K in Q4 2024. 125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

  • Invesco held 27,134 shares of Strata Critical Medical Inc worth $113K as of Q1 2026.
  • Invesco sold 4,941 Strata Critical Medical Inc shares in Q1 2026, an estimated $23.8K.
  • Strata Critical Medical Inc made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #3608 holding.
  • Invesco first reported a position in Strata Critical Medical Inc in Q2 2022 and has held it in 16 quarters since.
  • Invesco's Strata Critical Medical Inc position peaked at $477K in Q4 2024.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.